PUBLISHER: Grand View Research | PRODUCT CODE: 1530518
PUBLISHER: Grand View Research | PRODUCT CODE: 1530518
The global human milk oligosaccharides market size is expected to reach USD 732.23 million by 2030, registering a CAGR of 13.8% from 20254 to 2030, according to a new report by Grand View Research, Inc. The market growth is primarily driven by the rising demand for dietary supplements and an increasing awareness among consumers regarding the significance of gut health. Human milk oligosaccharides (HMOs) are crucial in maintaining gut health as they act as prebiotics in the human body. By promoting the growth of beneficial bacteria, particularly bifidobacteria, in the gut, HMOs enhance metabolic activity and contribute to overall well-being. The increasing recognition of HMO benefits continues to drive market growth.
Moreover, the antimicrobial protection and prebiotic properties of HMOs make them versatile ingredients that can be incorporated into various food products, such as infant formulas, pharmaceuticals, and functional foods, driving their demand. The market for HMOs is further bolstered by their essential role in infant nutrition, brain development, memory enhancement, and disease prevention. Furthermore, advancements in synthetic production methods have expanded the availability of HMOs beyond breast milk, catering to situations where breastfeeding may not be feasible. As consumer awareness continues to rise and demand for prebiotic-rich products escalates, the market for human milk oligosaccharides is expected to witness sustained growth driven by their unique health benefits across different age groups.